Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon… - Alzheimer's & …, 2023 - Wiley Online Library
Background Glial fibrillary acidic protein (GFAP) is a promising candidate blood‐based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …
被引用次数：22 相关文章

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon… - … & dementia: the …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

DIA Net - Alzheimer's & Dementia, 2023 - research-repository.uwa.edu.au
BackgroundGlial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …
[PDF] mq.edu.au

[PDF][PDF] Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon, S Pedrini… - 2022 - researchers.mq.edu.au
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …
[PDF] mq.edu.au

[PDF][PDF] Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon, S Pedrini… - 2022 - research-management.mq.edu.au
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

Dominantly Inherited Alzheimer … - Alzheimer s & …, 2022 - researchinformation.amsterdamumc …
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt… - Alzheimers & …, 2023 - tobias-lib.ub.uni-tuebingen.de
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations
with A beta-PET, neurodegeneration, and cognition Plasma glial fibrillary acidic protein in …

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition.

P Chatterjee, L Vermunt, BA Gordon… - … & Dementia: the …, 2022 - europepmc.org
Background Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …
[PDF] researchgate.net

[PDF][PDF] Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon, S Pedrini… - 2022 - researchgate.net
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …
[PDF] dzne.de

[PDF][PDF] Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

P Chatterjee, L Vermunt, BA Gordon, S Pedrini… - 2022 - pub.dzne.de
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based
biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its …